Metabolic Diseases

Interconnected cardiovascular, renal, and metabolic (CRM) diseases are the leading cause of death worldwide and account for up to 20 million deaths annually. By following the science, we are targeting specific pathways to address the interconnected nature of these diseases. Building on our expertise in developing innovative treatments for CRM conditions, our goal is to improve the lives of people living with these diseases, their families and the healthcare system.

Boehringer’s Commitment to Metabolic Diseases

Metabolic Diseases

Positioning in Cardiovascular, Renal and Metabolic Diseases

Our mission is to protect people from the consequences of cardiovascular, renal and metabolic diseases, and advocate for a shift from fragmented to integrated solutions that focus on prevention and treatment.

Metabolic Diseases

Partnering in Cardiovascular, Renal and Metabolic Diseases

Our commitment to collaboration with science-driven partners and academia is driven by our ambition to help change the future for people living with cardiovascular, renal and metabolic diseases

Metabolic Diseases

Innovation in Cardio-Renal-Metabolic Diseases

Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.